Hadassah

Success of Clinical Trial Brings Researchers Closer to a Cure for Blindness

Thursday, Dec 15 2011

Researchers at the Hadassah University Medical Center have completed a clinical trial which has successfully demonstrated the efficacy of gene therapy in restoring vision to patients with Leber’s Congenital Amaurosis (LCA), a genetic condition which causes severe visual impairment and eventual blindness.

Those with LCA experience poor night vision, low visual acuity, and a constricted visual field. The low vision continues to deteriorate, until the individual becomes totally blind. Some victims of LCA also suffer from crossed eyes, roving eye movements, unusual sensitivity to light, and/or cataracts. LCA is usually inherited as an autosomal recessive genetic condition.

The study, conducted by Dr. Eyal Banin of Hadassah's Center for Retinal and Macular Degeneration in collaboration with leading researchers in the United States and Great Britain, involved replacing the damaged RPE65 gene with a normal one. The procedure, whereby the gene was injected into the retina, also triggered renewed protein production.

Two participants in the study, Dana and Yossi, were treated with this gene therapy in just part of the retina of one eye, with dramatic results: A few weeks following treatment, both participants noted a substantial improvement in their vision.

"It was amazing because today I see things that I have never seen before," Yossi related. Dana noted that "learning of this new treatment was a life-changing event. I'm experiencing a real change." To hear directly from Dana and Yossi about the success of their treatment, click to http://www.mvrf.org/news.php.

Yossi and Dana's self-reporting of visual improvement is corroborated by objective, quantitative measurements of the treated area. With the continuation of this research, Hadassah's scientists will develop gene therapy to treat additional retinal degenerative diseases. "You cannot imagine what an effect this has had not only on the treated patients and their families," notes Dr. Banin, "but also on the wider population of patients with retinal and macular degenerations here in Israel, who suddenly feel some glimmer of hope." He added that "we feel very fortunate to have Macula Vision Research Foundation (MVRF) as our partners in this very exciting journey. Without funding from MVRF, we could not have conducted this clinical trial."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Dec 7 2016

Saturday Night Lively: Hadassah Israel Fundraiser Wows Largely Orthodox Audience of 1200

Hadassah International Israel (HII) drew over 1200 men and women to a concert at Tel Aviv University, targeting the funds raised for renovation of the rehabilitation facilities at Hadassah Hospital Mount Scopus.

READ MORE ›
alt_text

Monday, Dec 5 2016

Celebrated Israeli Psychiatrist/Neurobiologist To Join Hadassah Medical Staff

Prof. Yoram Yovell, renowned Israeli psychiatrist and neurobiologist, will soon be joining the Hadassah Medical Organization’s “brain medicine branch,” which includes the departments of psychiatry, neurology, and neurosurgery and is under the direction of Prof. Tamir Ben-Hur.

READ MORE ›
alt_text

Wednesday, Nov 30 2016

Hadassah Teams Up with Spinal Cord Institute to Study Outcomes of Traumatic Injuries

The medical interventions and outcomes for Israelis with a spinal cord injury (SCI) will now be captured in the Rick Hansen SCI Registry (RHSCIR), thanks to the November 16th launch of a partnership between the Hadassah Medical Organization and the Rick Hansen Institute (RHI), a Canadian-based not-for-profit organization named after the paralympic athlete who suffered a severe spinal cord injury following a car accident.

READ MORE ›
alt_text

Thursday, Nov 17 2016

Ethiopian Pre-Nursing Students: On the Way to Fulfilling a Dream

“I know that some people are fine with looking at a screen all day, but I know I need the human touch--to work with people. I want to be a nurse, " relates Sarah Talala, one of the 18 students of Ethiopian background who were given the opportunity to take a course which enabled them to advance to pre-academic studies at the Hebrew University and then on to nursing school at the Hadassah-Hebrew University Henrietta Szold School of Nursing.

READ MORE ›

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Membership Questions

membership@hadassah.org

(800) 664-5646

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Missions Department

missions@hadassah.org

(800) 237-1517

Show More